Skip to main content
Clinical Trials/NCT04161313
NCT04161313
Completed
N/A

Comparison of Respiratory Function, Exercise Capacity and Peripheral Muscle Strength Among Patients With Cystic Fibrosis, Primary Ciliary Dyskinesia and Healthy Children

Bezmialem Vakif University1 site in 1 country76 target enrollmentDecember 20, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Primary Ciliary Dyskinesia
Sponsor
Bezmialem Vakif University
Enrollment
76
Locations
1
Primary Endpoint
Six-minute walk test distance
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The aim of this study is to compare pulmonary function, respiratory muscle strength, exercise capacity and peripheral muscle strength of patients with CF, PCD and healthy childrens.

Detailed Description

The impaired airway clearence and pulmonary functions, exercise intolerance, low physical activity level and decreased peripheral muscle strength make physiotherapy approaches important in the management of CF and PCD.

Registry
clinicaltrials.gov
Start Date
December 20, 2019
End Date
March 12, 2020
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hilal Denizoğlu Külli

Lecturer in Department of Physiotheray and Rehabilitation

Bezmialem Vakif University

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of cystic fibrosis or primary ciliary dyskinesia

Exclusion Criteria

  • Hospitalization history in past month
  • Diagnosis of other chronic pediatric diseases which may impair exercise tolerance such as cerebral palsy or neuromuscular disease
  • Candidates for lung transplantation or history of lung transplantation

Outcomes

Primary Outcomes

Six-minute walk test distance

Time Frame: 15 minutes

Distance walked in six minutes will be recorded in meters. Test will be conducted according to the guideline of American Thoracic Society (ATS).

Secondary Outcomes

  • Forced Vital Capacity (FVC)(5 minutes)
  • Forced Expiratory Volume in 1 second (FEV1)(5 minutes)
  • Peak Expiratory Flow (PEF)(5 minutes)
  • M. Quadriceps strength(5 minutes)

Study Sites (1)

Loading locations...

Similar Trials